June 10, 2019 Intelligence: Late Breaking Lab News

By Robert Michel | From the Volume XXVI No. 8 – June 10, 2019 Issue

Digital pathology is coming in a big way to two regions in two different nations. In the United Kingdom, it was announced on May 30 that the North Tees and Hartlepool NHS Foundation in the north of England signed a five-year contract with Sectra of Linköping, Swed…

Read More

---

Why Pharma, Private Equity Want to Reshape Lab Industry

By Joseph Burns | From the Volume XXV No. 5 – March 26, 2018 Issue

CEO SUMMARY: A disruptive force that involves precision medicine, pharmaceutical companies, and venture capital investors is poised to reshape the clinical laboratory industry. Genetic knowledge makes it possible to match cancer drugs to specific mutations. Pharma companies and professio…

Read More

---

Direct Access Test Laboratories Targeted by NY State Attorney General

By Joseph Burns | From the Volume XXIII, No. 1 – January 19, 2016 Issue

CEO SUMMARY: Following an investigation of two lab companies providing direct access testing in New York State, the New York Attorney General entered into agreements with each lab company. Direct Laboratories, LLC, of Mandeville, Louisiana, agreed to cease offering DAT services in New Yor…

Read More

---

New Company Tracks Details and Prices For 60,000 Molecular and Genetic Tests

By Joseph Burns | From the Volume XXIII, No. 1 – January 19, 2016 Issue

CEO SUMMARY: Advances in the speed, accuracy, and cost of next-generation gene sequencing making it possible for clinical labs to create thousands of new tests. How many new tests? NextGxDx, an information technology company, says the nation’s clinical laboratories are introducing new m…

Read More

---

LabCorp, Sysmex Will Collaborate To Develop Liquid Biopsy Tests

By Robert Michel | From the Volume XXII NO. 9 – June 22, 2015 Issue

ANOTHER SIGN OF HEALTHCARE’S TRANSFORMATION came on June 1 when Sysmex Corporation of Kobe, Japan, and Laboratory Corporation of America in Burlington, North Carolina, announced a unique collaboration to develop blood-based molecular diagnostic tests for cancer. The collaboration call…

Read More

---

Tricare, DOD Not Paying for MoPath Codes, LDTs

By Joseph Burns | From the Volume XXI No. 1 – January 13, 2014 Issue

CEO SUMMARY: It turns out that labs serving Tricare patients are going unpaid for certain LDTs, molecular, and genetic tests. The issue of nonpayment began in January 2013 when Tricare stopped paying for these tests that were billed under the new molecular CPT codes that replaced the prev…

Read More

---

Several Laboratory Companies On Road to Public Stock Offering

By Robert Michel | From the Volume XVII No. 16 – November 15, 2010 Issue

ONE OF THE FEW PUBLIC STOCK OFFERINGS involving a lab testing company was completed last Wednesday. Exact Sciences, Inc., of Madison, Wisconsin sold $69 million worth of new shares to the public. Exact Sciences has proprietary diagnostic technology that it describes as “for noninv…

Read More

---

Many Questions About FDA Regulation of LDTs

By Robert Michel | From the Volume XVII No. 14 – October 4, 2010 Issue

CEO SUMMARY: Ask most pathologists and laboratory administrators about the FDA’s intent to regulate laboratory-developed tests (LDTs), and they will likely answer that it is to control web-based direct-to-consumer lab testing companies and the rapidly- growing number of proprie…

Read More

---

Two Big Pathology Groups Tap Investors for Capital

By Robert Michel | From the Volume XVII No. 2 – January 25, 2010 Issue

CEO SUMMARY: Pathology supergroups in California and Tennessee have each announced major recapitalizations. Both groups will use some of the money to cash out retiring partners. The balance of the new capital will be used to expand their businesses. With so many baby boomer pathologists a…

Read More

---

“June 28, 2004 Intelligence: Late Breaking Lab News”

By Robert Michel | From the Volume XI No. 9 – June 28, 2004 Issue

There’s early evidence that health benefit costs for 2005 may only increase by a single digit percentage. Hewitt Associates is gathering data from 160 large companies for its annual healthcare cost survey. It reports that an average increase of 13.7% appears likely, compared to a 1…

Read More

---